- Home
- SOPA vs RDHL Comparison
SOPA vs RDHL Comparison
Compare SOPA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- RDHL
- Stock Information
- Founded
- SOPA 2018
- RDHL 2009
- Country
- SOPA Singapore
- RDHL Israel
- Employees
- SOPA N/A
- RDHL N/A
- Industry
- SOPA EDP Services
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- SOPA Technology
- RDHL Health Care
- Exchange
- SOPA Nasdaq
- RDHL Nasdaq
- Market Cap
- SOPA 3.8M
- RDHL 3.9M
- IPO Year
- SOPA 2021
- RDHL N/A
- Fundamental
- Price
- SOPA $1.39
- RDHL $1.34
- Analyst Decision
- SOPA Strong Buy
- RDHL
- Analyst Count
- SOPA 1
- RDHL 0
- Target Price
- SOPA $15.00
- RDHL N/A
- AVG Volume (30 Days)
- SOPA 120.8K
- RDHL 142.3K
- Earning Date
- SOPA 08-13-2025
- RDHL 09-02-2025
- Dividend Yield
- SOPA N/A
- RDHL N/A
- EPS Growth
- SOPA N/A
- RDHL N/A
- EPS
- SOPA N/A
- RDHL N/A
- Revenue
- SOPA $7,522,939.00
- RDHL $8,042,999.00
- Revenue This Year
- SOPA N/A
- RDHL $381.91
- Revenue Next Year
- SOPA $45.16
- RDHL N/A
- P/E Ratio
- SOPA N/A
- RDHL N/A
- Revenue Growth
- SOPA 0.31
- RDHL 23.17
- 52 Week Low
- SOPA $0.64
- RDHL $1.06
- 52 Week High
- SOPA $6.75
- RDHL $12.50
- Technical
- Relative Strength Index (RSI)
- SOPA 55.45
- RDHL 42.30
- Support Level
- SOPA $1.10
- RDHL $1.31
- Resistance Level
- SOPA $1.49
- RDHL $1.48
- Average True Range (ATR)
- SOPA 0.15
- RDHL 0.09
- MACD
- SOPA 0.02
- RDHL 0.03
- Stochastic Oscillator
- SOPA 55.57
- RDHL 65.48
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.